BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 30871021)

  • 1. The Role of Curcumin in the Modulation of Ageing.
    Bielak-Zmijewska A; Grabowska W; Ciolko A; Bojko A; Mosieniak G; Bijoch Ł; Sikora E
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging senolytic agents derived from natural products.
    Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R
    Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence.
    Bahrami A; Montecucco F; Carbone F; Sahebkar A
    Biomed Res Int; 2021; 2021():8972074. PubMed ID: 34692844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
    Chandrakar L; Ambatwar R; Khatik GL
    Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of aging and potential role of selected polyphenols in extending healthspan.
    Russo GL; Spagnuolo C; Russo M; Tedesco I; Moccia S; Cervellera C
    Biochem Pharmacol; 2020 Mar; 173():113719. PubMed ID: 31759977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senolytics and the compression of late-life mortality.
    Kowald A; Kirkwood TBL
    Exp Gerontol; 2021 Nov; 155():111588. PubMed ID: 34637949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuins, a promising target in slowing down the ageing process.
    Grabowska W; Sikora E; Bielak-Zmijewska A
    Biogerontology; 2017 Aug; 18(4):447-476. PubMed ID: 28258519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Potential of Senolytic Drugs.
    Kirkland JL; Tchkonia T; Zhu Y; Niedernhofer LJ; Robbins PD
    J Am Geriatr Soc; 2017 Oct; 65(10):2297-2301. PubMed ID: 28869295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The curcumin analog EF24 is a novel senolytic agent.
    Li W; He Y; Zhang R; Zheng G; Zhou D
    Aging (Albany NY); 2019 Jan; 11(2):771-782. PubMed ID: 30694217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies.
    Toutfaire M; Bauwens E; Debacq-Chainiaux F
    Biochem Pharmacol; 2017 Oct; 142():1-12. PubMed ID: 28408343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Towards success against senescence?].
    Jordan B
    Med Sci (Paris); 2018 Oct; 34(10):885-890. PubMed ID: 30451682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of curcumin in aging and senescence: Molecular mechanisms.
    Zia A; Farkhondeh T; Pourbagher-Shahri AM; Samarghandian S
    Biomed Pharmacother; 2021 Feb; 134():111119. PubMed ID: 33360051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
    Zhu Y; Tchkonia T; Pirtskhalava T; Gower AC; Ding H; Giorgadze N; Palmer AK; Ikeno Y; Hubbard GB; Lenburg M; O'Hara SP; LaRusso NF; Miller JD; Roos CM; Verzosa GC; LeBrasseur NK; Wren JD; Farr JN; Khosla S; Stout MB; McGowan SJ; Fuhrmann-Stroissnigg H; Gurkar AU; Zhao J; Colangelo D; Dorronsoro A; Ling YY; Barghouthy AS; Navarro DC; Sano T; Robbins PD; Niedernhofer LJ; Kirkland JL
    Aging Cell; 2015 Aug; 14(4):644-58. PubMed ID: 25754370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Glycosides as Senolytic Compounds.
    Martin N; Soriani O; Bernard D
    Trends Mol Med; 2020 Mar; 26(3):243-245. PubMed ID: 31983612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-senescence compounds: A potential nutraceutical approach to healthy aging.
    Gurău F; Baldoni S; Prattichizzo F; Espinosa E; Amenta F; Procopio AD; Albertini MC; Bonafè M; Olivieri F
    Ageing Res Rev; 2018 Sep; 46():14-31. PubMed ID: 29742452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cellular senescence in aging through the prism of Koch-like criteria.
    Yanai H; Fraifeld VE
    Ageing Res Rev; 2018 Jan; 41():18-33. PubMed ID: 29106993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting normal and cancer senescent cells as a strategy of senotherapy.
    Sikora E; Bielak-Zmijewska A; Mosieniak G
    Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application potential of senolytics in clinical treatment.
    Li T; Li S; Ma K; Kong J
    Biogerontology; 2024 Jun; 25(3):379-398. PubMed ID: 38109001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
    Romashkan S; Chang H; Hadley EC
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Senolytics in Cardiovascular Disease.
    Dookun E; Passos JF; Arthur HM; Richardson GD
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.